- Home
- KMDA vs MLP Comparison
KMDA vs MLP Comparison
Compare KMDA & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- MLP
- Stock Information
- Founded
- KMDA 1990
- MLP 1909
- Country
- KMDA Israel
- MLP United States
- Employees
- KMDA N/A
- MLP N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- MLP Real Estate
- Sector
- KMDA Health Care
- MLP Finance
- Exchange
- KMDA Nasdaq
- MLP Nasdaq
- Market Cap
- KMDA 410.6M
- MLP 343.9M
- IPO Year
- KMDA N/A
- MLP 1972
- Fundamental
- Price
- KMDA $7.32
- MLP $16.96
- Analyst Decision
- KMDA Strong Buy
- MLP
- Analyst Count
- KMDA 2
- MLP 0
- Target Price
- KMDA $13.00
- MLP N/A
- AVG Volume (30 Days)
- KMDA 51.8K
- MLP 16.5K
- Earning Date
- KMDA 08-13-2025
- MLP 08-14-2025
- Dividend Yield
- KMDA 2.80%
- MLP N/A
- EPS Growth
- KMDA 27.97
- MLP N/A
- EPS
- KMDA 0.32
- MLP N/A
- Revenue
- KMDA $169,517,000.00
- MLP $16,843,000.00
- Revenue This Year
- KMDA $14.49
- MLP N/A
- Revenue Next Year
- KMDA $10.12
- MLP N/A
- P/E Ratio
- KMDA $21.69
- MLP N/A
- Revenue Growth
- KMDA 9.67
- MLP 74.59
- 52 Week Low
- KMDA $5.17
- MLP $14.05
- 52 Week High
- KMDA $9.16
- MLP $25.78
- Technical
- Relative Strength Index (RSI)
- KMDA 54.83
- MLP 49.31
- Support Level
- KMDA $6.90
- MLP $16.79
- Resistance Level
- KMDA $7.43
- MLP $17.55
- Average True Range (ATR)
- KMDA 0.19
- MLP 0.51
- MACD
- KMDA 0.03
- MLP 0.03
- Stochastic Oscillator
- KMDA 80.19
- MLP 68.95
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.